Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Ng

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Critical Care Medicine|April 1, 2020
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2024
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICUAnthony C Gordon, Narges Alipanah-Lechner, Lieuwe D Bos, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Critical Care (London, England)|February 8, 2013
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryKianoush Kashani, Ali Al-Khafaji, Thomas Ardiles, et al.
Critical Care Medicine|February 8, 2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First UpdateWaleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Intensive Care Medicine|March 24, 2026
Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)Marc Leone, Sheila N Myatra, Siddharth Dugar, et al.
Critical Care Medicine|March 24, 2026
Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)Marc Leone, Sheila N Myatra, Siddharth Dugar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Critical Care Medicine|April 1, 2020
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2024
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICUAnthony C Gordon, Narges Alipanah-Lechner, Lieuwe D Bos, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Critical Care (London, England)|February 8, 2013
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryKianoush Kashani, Ali Al-Khafaji, Thomas Ardiles, et al.
Critical Care Medicine|February 8, 2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First UpdateWaleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Intensive Care Medicine|March 24, 2026
Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)Marc Leone, Sheila N Myatra, Siddharth Dugar, et al.
Critical Care Medicine|March 24, 2026
Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)Marc Leone, Sheila N Myatra, Siddharth Dugar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Pageof 16